FDA Renews Attack on Homeopathy

The agency is doubling down on a bad guidance that endangers access to important medicines. Action Alert! Recently, the FDA announced the withdrawal of Compliance Policy Guide 400.400, a document that had been in place since 1988 and which established the agency’s enforcement policies regarding homeopathic medicines. In its place, the FDA has issued a… Continue reading FDA Renews Attack on Homeopathy

“Approved” “Hormone Therapy” For Women is Mostly Not Bio-Identical, is “One-Size-Fits-All,” and Not Safe for Use

The following article is by Dr. Jonathan V. Wright. The original article appears in the November 2019 issue of the Green Medicine Newsletter. Action Alert! The September 24th issue of the Journal of the American Medical Association (“JAMA”) reprinted[1] an article originally published in The Medical Letter on Drugs and Therapeutics which told us about the… Continue reading “Approved” “Hormone Therapy” For Women is Mostly Not Bio-Identical, is “One-Size-Fits-All,” and Not Safe for Use

Proton Pump Inhibitors (PPIs) and kidney disease

Millions of Americans have taken PPIs like Prilosec, Nexium and Prevacid to treat heartburn. These drugs have been promoted as a safe and more effective alternative to other antacid treatments and have been widely prescribed. These drugs, however, can allegedly cause extensive kidney damage. Numerous studies have shown the potential for injury from PPI use,… Continue reading Proton Pump Inhibitors (PPIs) and kidney disease

Published
Categorized as Archives

Incretin Mimetics and pancreatic complications

Incretin mimetics are a class of drugs used to Type 2 diabetes. Recent studies have shown that incretin mimetics are linked with pancreatic cancer. In 2013, the FDA released unpublished academic research that demonstrated pre-cancerous cellular changes known as pancreatic duct metaplasia in Type 2 diabetic patients treated with incretin mimetics. Incretin mimetics act like… Continue reading Incretin Mimetics and pancreatic complications

Published
Categorized as Archives

Taxotere and permanent hair loss

Taxotere is a plant alkaloid chemotherapy drug derived from the yew tree. Taxotere is used intravenously in patients with locally advanced or metastatic breast cancer (after failure of prior chemotherapy) and in conjunction with doxorubicin and cyclophosphamide in patients with operable node-positive breast cancer. Unfortunately, it appears as though Taxotere is no more effective than… Continue reading Taxotere and permanent hair loss

Published
Categorized as Archives

Valsartan and cancer, liver damage

Valsartan is an angiotensin-receptor blocker which is prescribed to patients with high blood pressure or congestive heart failure. Valsartan is widely manufactured overseas. Unfortunately, the Food and Drug Administration (FDA) has found Valsartan drugs made by generic manufacturers to be contaminated with N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). These impurities may have the potential to cause… Continue reading Valsartan and cancer, liver damage

Published
Categorized as Archives